Short Summary
Sun Pharma Laboratories Limited filed a commercial IP suit against Madhusudan Pharmaceutical Agency and others alleging infringement of its registered trade mark 'PANTOCID-DSR'. The court granted leave under Clause XIV of the Letters Patent Act and passed an interim order restraining the defendants from dealing in products bearing the impugned trademark.
Detailed Summary
In the pharmaceutical world, a brand name is more than a label — it is the cumulative trust of doctors, pharmacists, and patients built over years of consistent quality. When a competitor attempts to cash in on that hard-earned reputation by mimicking a well-known mark, the original owner must act fast, because every prescription filled under a confusingly similar name is a potential risk to patients and a direct hit to brand equity. This case is a textbook example of how a major pharmaceutical company moved swiftly to protect one of its flagship trademarks from being diluted in the marketplace.
Sun Pharma Laboratories Limited, a prominent player in the pharmaceutical industry, held the registered trademark 'PANTOCID-DSR' — a brand that had clearly carved out recognition in its segment. The company found that Madhusudan Pharmaceutical Agency and others were dealing in products bearing a mark that allegedly infringed upon its registered rights. Rather than waiting for the dispute to drag on, Sun Pharma filed a commercial IP suit and sought urgent interim relief to stop the alleged infringement in its tracks. The matter came up before the court on 16 April 2019, where the company pressed for immediate protection of its trademark.
Sun Pharma argued that it was the rightful registered proprietor of the trademark 'PANTOCID-DSR' and that the defendants were using a deceptively similar mark on their pharmaceutical products, which was likely to cause confusion in the market and dilute the distinctiveness of its established brand. The defendants, on the other hand, contested the claim, putting the plaintiff in the position of having to demonstrate a prima facie case of infringement and the urgency justifying interim restraint. The core legal friction centered on whether the use of the impugned mark by the defendants amounted to infringement of Sun Pharma's registered trademark and whether the court should step in before the final hearing to prevent further damage.
The court granted leave under Clause XIV of the Letters Patent Act, signaling its willingness to entertain the suit on its merits. More importantly, it passed an interim order restraining the defendants from dealing in products bearing the impugned trademark. This temporary injunction meant that, pending the final disposal of the suit, the defendants could not continue to trade in the allegedly infringing product. The court's decision underscored the seriousness with which it viewed the prima facie case of trademark infringement and the need to preserve the status quo until the matter could be fully adjudicated.
For founders and IP professionals, this case is a clear reminder that speed matters when it comes to trademark enforcement. The moment you spot a potentially infringing mark in the market, filing for interim relief — rather than waiting for a full trial — can be the difference between protecting your brand's reputation and watching it erode. Registering your trademark is only the first step; actively monitoring the market and being prepared to invoke interim remedies under the relevant procedural provisions is what turns a registered mark into real, enforceable protection.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in trademark matters before Bombay High Court. Understanding the court's reasoning in Sun Pharma Laboratories Limited vs Madhusudan Pharmaceutical Agency and another is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Mahesh Namkeen Pvt. Ltd.vsOm Prakash Nebhwani (Trading as: Mahesh Matar Namkeen)
Mahesh Namkeen Pvt. Ltd., a Lucknow-based company engaged in manufacturing namkeens and snacks since 1983 under the trademark 'MAHESH' (with parrot device), sued Om Prakash Nebhwani for trademark infringement and passing off. The defendant, who is the nephew of the plaintiff's director and had prior knowledge of the mark, adopted the identical 'MAHESH' mark with parrot/peacock device for his own namkeen business in Jaipur. The defendant's defense was struck off for non-filing of written statement. The court found the plaintiff's mark to be distinctive, well-established, and a well-known trademark, and held that the defendant's use constituted slavish copying amounting to infringement and passing off.
Ms Pas AgrovsM/S Krbl Limited & Anr
Ms Pas Agro has filed a petition under Section 124(1)(b)(ii) of the Trademarks Act challenging the Commercial Court's order dismissing its application to frame a preliminary issue on the invalidity of KRBL's registered trademark 'INDIA GATE' (application no. 599833). The underlying suit CS (COMM) 78/2025 was filed by KRBL against Pas Agro. The Delhi High Court issued notice, permitted deletion of respondent no.2, and granted time for filing reply and rejoinder. The substantive question of whether a preliminary issue on trademark invalidity should be framed remains pending.
Cryogas Equipment Private LimitedvsInox India Limited & Ors.
The Supreme Court disposed of a miscellaneous application seeking extension of time for the trial court to decide Trademark Suit No. 3 of 2019 between Cryogas Equipment Private Limited and Inox India Limited. As a last opportunity, the Court granted an additional six months to the concerned court to decide the suit, while expressly warning that no further extension would be entertained. The underlying dispute concerns trademark rights in the cryogenic/industrial gas equipment sector.
Mankind Consumer Products Private LimitedvsAlaina Healthcare Private Limited & A. Menarini India Private Limited
Mankind Consumer Products, the registered proprietor of the trademark ACNESTAR (Reg. No. 1352577 in Class 5) since 2005, sued Alaina Healthcare and A. Menarini India for using the marks ACNE SCAR/ACNE+SCAR/ACNESCAR on their acne scar serum product HEXILAK. The court found a prima facie case of deceptive similarity, noting that the dominant feature 'ACNE' was common and the suffix 'STAR' vs 'SCAR' was insufficient to distinguish the marks, especially given the identical trade channels and consumer class. The court granted an interim injunction in favour of the plaintiff while allowing defendant no. 2 a two-month period to recall existing stock from the trade.
Healthium Medtech Limited (earlier Healthium Medtech Private Limited)vsThe Registrar of Trade Marks, Chennai
Healthium Medtech Limited filed a writ petition seeking a mandamus to compel the Registrar of Trade Marks to expeditiously dispose of Opposition No. 1027536 filed by Glenmark Pharmaceuticals against Healthium's trademark application No. 4270882 for the 'Healthium' device mark in Classes 05 and 10. The petitioner complained that despite evidence having been adduced, the opposition proceedings remained pending without a final hearing. The Madras High Court allowed the writ petition and directed the Registrar to hear both parties and dispose of the opposition on merits within four weeks.
CavinKare Private LimitedvsMaha Aqua, Trading As Mahalakshmi Aqua
CavinKare Private Limited filed a trademark infringement suit against Maha Aqua (trading as Mahalakshmi Aqua) seeking a permanent injunction to restrain the defendant from using the mark 'MAA' or any deceptively similar mark in respect of goods in Class 32. The plaintiff relies on its registered trademarks 'MAA' under Nos. 1109946 and 6453733. The Court, after issues were framed and affidavits of admission/denial filed, approved a Joint Case Management Schedule suggested by both parties and set timelines for completion of evidence and oral arguments.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.